1. Preclinical evaluation of the ANCD thrombectomy device: safety and efficacy in a swine clot model
- Author
-
Christophe Cognard, Lynn Bailey, Anna Rios, Raul G Nogueira, Helena Villanova, Tommy Andersson, Rebecca Ducore, Sonia Sanchez, Iñaki Galve, and Marc Ribó
- Subjects
Male ,Solitaire Cryptographic Algorithm ,Swine ,Cervical Artery ,medicine.medical_treatment ,Revascularization ,medicine ,Animals ,Stroke ,Thrombectomy ,business.industry ,Cerebral infarction ,Thrombosis ,General Medicine ,Blood flow ,Thrombolysis ,medicine.disease ,Disease Models, Animal ,Treatment Outcome ,Reperfusion ,Stents ,Surgery ,Neurology (clinical) ,Nuclear medicine ,business ,Perfusion - Abstract
BackgroundThe Advanced Thrombectomy System (ANCD) provides a new funnel component designed to reduce clot fragmentation and facilitate retrieval in patients with stroke by locally restricting flow, allowing distal aspiration in combination with a stent retriever (SR).ObjectiveTo evaluate the preclinical efficacy and safety of the ANCD in a swine clot model.MethodsSoft and firm clots were implanted in the lingual and cervical arteries of 11 swine to obtain Thrombolysis in Cerebral Infarction (TICI) 0 blood flow. Mechanical thrombectomy was performed with either a balloon guide catheter+Solitaire 2 stent retriever (BGC+SR, n=13) or ANCD+SR (n=13). TICI flow was evaluated and successful revascularization was defined as TICI 3 (normal perfusion). To characterize safety, a total of 3 passes were performed in each vessel independent of recanalization. Tissues were explanted for histopathological analysis after 3 and 30 days, respectively.ResultsFirst pass reperfusion rates were ANCD+SR: 69% and BGC+SR: 46%. Reperfusion increased after the third pass in both groups (ANCD+SR: 100%, vs BGC+SR: 77%). Recanalization was achieved after an average of 1.4 and 1.9 passes in ANCD+SR and BGC+SR (p=0.095), respectively. Vessel injury was comparable in both groups; endothelial loss at 3 days was the most common injury seen (ANCD+SR: 1.78±1.22; BGC+SR: 2.03±1.20; p=0.73), while other histopathological markers were absent or minimal. Tissues downstream from targeted vessels also showed absence or minimal lesions across both groups.ConclusionsResults in a swine clot model support the high efficacy of the ANCD+SR without causing clinically significant vessel injury potentially related to the new funnel component.
- Published
- 2020
- Full Text
- View/download PDF